Overview

In Clinic Optometrist Insertion of Dextenza Prior to Cataract Surgery

Status:
Not yet recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
To evaluate the clinical outcomes with optometrist pre-surgical insertion of DEXTENZA in the clinical office setting in patients undergoing same-day cataract surgery compared to standard of care steroid therapy.
Phase:
Phase 4
Details
Lead Sponsor:
Mitchel Ibach
Collaborator:
Ocular Therapeutix, Inc.
Treatments:
Prednisolone